Health benefit of fucosterol from marine algae: A review

Journal of the Science of Food and Agriculture

Volumn 96, Issue 6, 2016, Pages 1856-1866

  Abdul, Qudeer Ahmed ^a   Choi, Ran Joo ^b   Jung, Hyun Ah ^c   Choi, Jae Sue ^a  

^a Pukyong National University   (South Korea)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Chonbuk National University   (South Korea)

Author keywords

Fucosterol; Health benefit; Marine algae; Nutraceutical

Indexed keywords

FUCOSTEROL; STIGMASTEROL;

ANALOGS AND DERIVATIVES; AQUATIC SPECIES; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; SEAWEED;

AQUATIC ORGANISMS; HUMANS; MOLECULAR STRUCTURE; SEAWEED; STIGMASTEROL;

EID: 84960442278     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.7489     Document Type: Review

References (83)

1. Faulkner DJ, Marine natural products. Nat Prod Rep 19:1-48 (2002).
2. Lee S, Lee YS, Jung SH, Kang SS and Shin KH, Anti-oxidant activities of fucosterol from the marine algae Pelvetia siliquosa. Arch Pharm Res 26:719-722 (2003).
3. Jung HA, Jin SE, Ahn BR, Lee CM and Choi JS, Anti-inflammatory activity of edible brown alga Eisenia bicyclis and its constituents fucosterol and phlorotannins in LPS-stimulated RAW264.7 macrophages. Food Chem Toxicol 59:199-206 (2013).
4. Bang MH, Kim HH, Lee DY, Han MW, Baek YS, Chung DK et al., Anti-osteoporotic activities of fucosterol from sea mustard (Undaria pinnatifida). Food Sci Biotechnol 20:343-347 (2011).
5. Huh GW, Lee DY, In SJ, Lee DG, Park SY, Yi TH et al., Fucosterols from Hizikia fusiformis and their proliferation activities on osteosarcoma-derived cell MG63. J Korean Soc Appl Biol Chem 55:551-555 (2012).
6. Heilbron I, Phipers RF and Wright HR, The chemistry of the algae. Part I. The algal sterol fucosterol. J Chem Soc 1572-1576 (1934).
7. Willstätter R and Page HJ, Über die pigmente der Braunalgen. Justus Liebigs Ann Chem 404:237-271 (1914).
8. Shirahama K, On the unsaponifiable matter and phosphatides in marine algae fat. J Fac Agric Hokkaido Univ 49:1-93 (1942).
9. Carter PW, Heilbron IM and Lythgoe B, The lipochromes and sterols of the algal classes. Proc R Soc Lond B 128:82-109 (1940).
10. Khanavi M, Gheidarloo R, Sadati N, Ardekani MRS, Nabavi SMB, Tavajohi S et al., Cytotoxicity of fucosterol containing fraction of marine algae against breast and colon carcinoma cell line. Pharmacogn Mag 8:60-64 (2012).
11. Hoang MH, Jia Y, Jun HJ, Lee JH, Lee BY and Lee SJ, Fucosterol is a selective liver X receptor modulator that regulates the expression of key genes in cholesterol homeostasis in macrophages, hepatocytes, and intestinal cells. J Agric Food Chem 60:11567-11575 (2012).
12. Lee YS, Shin KH, Kim BK and Lee S, Anti-diabetic activities of fucosterol from Pelvetia siliquosa. Arch Pharm Res 27:1120-1122 (2004).
13. Rajendran I, Chakraborty K, Vijayan KK and Vijayagopal P, Bioactive sterols from the brown alga Anthophycus longifolius (Turner) Kützing, 1849 (= Sargassum longifolium). Indian J Fish 60:83-86 (2013).
14. Caamal-Fuentes E, Moo-Puc R, Freile-Pelegrín Y and Robledo D, Cytotoxic and antiproliferative constituents from Dictyota ciliolata, Padina sanctae-crucis and Turbinaria tricostata. Pharm Biol 27:1-5 (2014).
15. Jung HA, Jung HJ, Jeong HY, Kwon HJ, Kim MS and Choi JS, Anti-adipogenic activity of the edible brown alga Ecklonia stolonifera and its constituent fucosterol in 3 T3-L1 adipocytes. Arch Pharm Res 37:713-720 (2014).
16. Yoon NY, Chung HY, Kim HR and Choi JS, Acetyl- and butyrylcholinesterase inhibitory activities of sterols and phlorotannins from Ecklonia stolonifera. Fish Sci 74:200-207 (2008).
17. Jung HA, Islam MN, Lee CM, Oh SH, Lee S, Jung JH et al., Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera. Chem Biol Interact 206:55-62 (2013).
18. Santoyo S, Plaza M, Jaime L, Ibañez E, Reglero G and Señorans J, Pressurized liquids as an alternative green process to extract antiviral agents from the edible seaweed Himanthalia elongata. J Appl Psychol 23:909-917 (2011).
19. Hwang E, Park SY, Shin HS, Lee DG and Yi TH, Effect of oral administration of fucosterol from Hizikia fusiformis on DNCB-induced atopic dermatitis in NC/Nga mice. Food Sci Biotechnol 23:593-599 (2014).
20. Atta-Ur-Rahman, Choudhary MI, Majeed A, Shabbir M, Ghani U and Shameel M, A succinylanthranilic acid ester and other bioactive constituents of Jolyna laminarioides. Phytochemistry 46:1215-1218 (1997).
21. Lee DG, Park JH, Yoo KH, Chung IS, Lee YH, Lee JK et al., 24-Ethylcholesta-4, 24(28)-dien-3, 6-dione from Osmanthus fragrans var. aurantiacus flowers inhibits the growth of human colon cancer cell line, HCT-116. J Korean Soc Appl Biol Chem 54:206-210 (2011).
22. Tang HF, Yi YH, Yao XS, Xu QZ, Zhang SY and Lin HW, Bioactive steroids from the brown alga Sargassum carpophyllum. J Asian Nat Prod Res 4:95-101 (2002).
23. Chen Z1, Liu J, Fu Z, Ye C, Zhang R, Song Y et al., 24(S)-Saringosterol from edible marine seaweed Sargassum fusiforme is a novel selective LXRβ agonist. J Agric Food Chem 62:6130-6137 (2014).
24. Ayyad SE, Ezmirly ST, Basaif SA, Alarif WM, Badria AF and Badria FA, Antioxidant, cytotoxic, antitumor, and protective DNA damage metabolites from the red sea brown alga Sargassum sp. Pharmacognosy Res 3:160-165 (2011).
25. Kim KN, Ham YM, Moon JY, Kim MJ, Kim DS, Lee WJ et al., In vitro cytotoxic activity of Sargassum thunbergii and Dictyopteris divaricata (Jeju Seaweeds) on the HL-60 tumour cell line. Int J Pharmacol 5:298-306 (2009).
26. Byju K, Anuradha V, Vasundhara G, Nair SM and Kumar NC, In vitro and in silico studies on the anticancer and apoptosis-inducing activities of the sterols identified from the soft coral, Subergorgia reticulata. Pharmacogn Mag 10:65-71 (2014).
27. Hashim MA, Yam MF, Hor SY, Lim CP, Asmawi MZ and Sadikun A, Anti-hyperglycaemic activity of Swietenia macrophylla King (Meliaceae) seed extracts in normoglycaemic rats undergoing glucose tolerance tests. Chin Med 8:11-19 (2013).
28. Kumar SS, Kumar Y, Khan MS and Gupta V, New antifungal steroids from Turbinaria conoides (J. Agardh) Kutzing. Nat Prod Res 24:1481-1487 (2010).
29. Kumar SS, Kumar Y, Khan MSY, Anbu J and De Clercq E, Anti-histaminic, anti-cholinergic and antiviral activities of fucosterol from Turbinaria conoides (J. Agardh) Kutzing. Pharmacologyonline 1:1104-1112 (2009).
30. Yoo MS, Shin JS, Choi HE, Cho YW, Bang MH, Baek IN et al., Fucosterol isolated from Undaria pinnatifida inhibits lipopolysaccharide-induced production of nitric oxide and pro-inflammatory cytokines via the inactivation of nuclear factor-κB and p38 mitogen-activated protein kinase in RAW 264.7 macrophages. Food Chem 135:967-975 (2012).
31. Ji YB, Ji CF and Yue L, Study on human promyelocytic leukemia HL-60 cells apoptosis induced by fucosterol. Biomed Mater Eng 24:845-851 (2014).
32. Ji YB, Song DX and Ji CF, Study on apoptosis of human promyelocytic leukemia HL-60 cells induced by fucosterol via death receptor pathway. Adv Mat Res 790:607-610 (2013).
33. Hwang E, Park SY, Sun ZW, Shin HS, Lee DG and Yi TH, The protective effects of fucosterol against skin damage in UVB-irradiated human dermal fibroblasts. Mar Biotechnol 16:361-370 (2014).
34. Kim MS, Oh GH, Kim MJ and Hwang JK, Fucosterol inhibits matrix metalloproteinase expression and promotes type-1 procollagen production in UVB-induced HaCaT cells. Photochem Photobiol 89:911-918 (2013).
35. Hagiwara H, Wakita K, Inada Y and Hirose S, Fucosterol decreases angiotensin converting enzyme levels with reduction of glucocorticoid receptors in endothelial cells. Biochem Biophys Res Commun 139:348-352 (1986).
36. Whiting DR, Guariguata L, Weil C and Shaw J, IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311-321 (2011).
37. World Health Organization, Definition, Diagnosis and Classification of Diabetes mellitus and its complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes mellitus. World Health Organization, Geneva (1999).
38. Alberti KG and Zimmet PZ, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539-553 (1998).
39. Burton GJ and Jauniaux E, Oxidative stress. Best Pract Res Clin Obstet Gynaecol 25:287-299 (2011).
40. Campos MGR, Frigerio C, Lopes J and Bogdanov S, What is the future of Bee-Pollen? J ApiProduct ApiMed Sci 2:131-144 (2010).
41. Gokhale AB, Damre AS, Kulkami KR and Saraf MN, Preliminary evaluation of anti-inflammatory and anti-arthritic activity of Saussurea lappa, Argyreia speciosa and Achyranthes aspera. Phytomedicine 9:433-437 (2002).
42. Hou C, Kirchner T, Singer M, Matheis M, Argentieri D and Cavender D, In vivo activity of phospholipase C inhibitor, 1-(6-((17β-3-methoxyestra-1, 3, 5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2, 5-dione (U73122), in chronic and acute inflammatory reactions. J Pharmacol Exp Ther 309:697-704 (2004).
43. Vijyalakshmi T, Muthulakshmi V and Sachdanandam P, Salubrious effect of Semecarpus anacardium against lipid peroxidative changes in adjuvant arthritis studied in rats. Mol Cell Biochem 175:65-69 (1997).
44. Safayhi H and Sailer ER, Anti-inflammatory actions of pentacyclic triterpenes. Planta Med 63:487-493 (1997).
45. Rodders J, Speedie M and Tyler V, Pharmacognosy and Pharmacobiotecknology. Williams & Wilkins, Baltimore, MD, pp. 1-14 (1996).
46. Mroueh M, Saab Y and Rizkalla R, Hepatoprotective activity of Centaurium erythraea on acetaminophen-induced hepatotoxicity in rats. Phytother Res 18:431-433 (2004).
47. Srivastava A and Shivanandappa T, Hepatoprotective effect of the root extract of Decalepis hamiltonii against carbon tetrachloride-induced oxidative stress in rats. Food Chem 118:411-417 (2010).
48. Navarro VJ and Senior JR, Drug-related hepatotoxicity. N Engl J Med 354:731-739 (2006).
49. Smuckler EA, Alcoholic drink: its production and effects. Fed Proc 34:2038-2044 (1975).
50. Choi JS, Han YR, Byeon JS, Choung SY, Sohn HS and Jung HA. Protective effect of fucosterol isolated from the edible brown algae, Ecklonia stolonifera and Eisenia bicyclis, on the tert-BHP and tacrine-induced HepG2 cell injury. J Pharm Pharmacol 67:1170-1178 (2015).
51. Levi F, Lucchini F, Negri E and Vecchia CL, The decline in cancer mortality in the European Union, 1988-1996. Eur J Cancer 36:1965-1968 (2000).
52. Hersey P and Zhang XD, How melanoma cells evade trail-induced apoptosis. Nat Rev Cancer 1:142-150 (2001).
53. Taraphdar AK, Roy M and Bhattacharya RK, Natural products as inducers of apoptosis: implication for cancer therapy and prevention. Curr Sci 80:1387-1396 (2001).
54. Debatin KM, Poncet D and Kroemer G, Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 21:8786-8803 (2002).
55. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE et al., Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669-677 (1992).
56. Fox KM, Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362:782-788 (2003).
57. Group I-4 C, ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58, 050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative. Lancet 345:669-685 (1995).
58. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F et al., A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325:303-310 (1991).
59. Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C et al., Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD echocardiography substudy. Circulation 91:2573-2581 (1995).
60. Luders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M et al., The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens 26:1487-1496 (2008).
61. Barker JN, Palmer CN, Zhao Y, Liao H, Hull PR, Lee SP et al., Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 127:564-567 (2007).
62. + memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern:IgG4 counterregulation by CLA-memory T cells. J Immunol 159:4611-4619 (1997).
63. Van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, Maggi E, Romagnani S, Westland JK et al., Skin-derived aeroallergen specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 90:184-193 (1992).
64. Lee JK, Ha H, Lee HY, Park SJ, Jeong SL, Choi YJ et al., Inhibitory effects of heartwood extracts of Broussonetia kazinokisieb on the development of atopic dermatitis in NC/Nga mice. Biosci Biotechnol Biochem 74:1802-1806 (2010).
65. Blume-Peytavi U and Wahn U, Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate. J Eur Acad Dermatol Venereol 25:508-515 (2011).
66. Hengge UR, Ruzicka T, Schwartz RA and Cork MJ, Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 54:1-15 (2006).
67. Dimitriou R, Jones E, McGonagle D and Giannoudis PV, Bone regeneration: current concepts and future directions. BMC Med 9:66 (2011).
68. Einhorn TA, The cell and molecular biology of fracture healing. Clin Orthop Relat Res 355(Suppl):S7-S21 (1998).
69. Cho TJ, Gerstenfeld LC and Einhorn TA, Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17:513-520 (2002).
70. Lee DG, Park SY, Chung WS, Park JH, Shin HS, Hwang E et al., The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis. Mol Nutr Food Res 58:1249-1257 (2014).
71. Vinholes J, Grosso C, Andrade PB, Gil-Izquierdo A, Valentao P, Pinho PGD et al., In vitro studies to assess the anti-diabetic, anti-cholinesterase and anti-oxidant potential of Spergularia rubra. Food Chem 129:454-462 (2011).
72. Mukherjee PK, Kumar V, Mal M and Houghton PJ, Acetylcholinesterase inhibitors from plants. Phytomedicine 14:289-300 (2007).
73. Smith SC, Jackson R and Pearson TA, Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the world health and stroke forum. Circulation 109:3112-3121 (2004).
74. Yang YH, Jun Y and Qing HJ, Hypolipidemic effect of gypenosides in experimentally induced hypercholesterolemic rats. Lipids Health Dis 12:154 (2013).
75. Lee SJ, Kim CW, Jang HJ, Cho SY and Choi JW, Anti-hyperlipidemia and anti-arteriosclerosis effects of Laminaria japonica in Sprague-Dawley rats. Fish Aquat Sci 14:235-241 (2011).
76. Yim MJ, Anti-atherosclerosis animal study and the key functional compound: identification of the alginate extracted residue of sea tangle. MS thesis, Graduate School of Gangneung National University, Gangneung, KR (2007).
77. Vahouny GV, Connor WE, Subramaniam S, Lin DS and Gallo LL, Comparative lymphatic absorption of sitosterol, stigmasterol, and fucosterol and differential inhibition of cholesterol absorption. Am J Clin Nutr 37:805-809 (1983).
78. Ikeda I, Tanaka K, Sugano M, Vahouny GV and Gallo LL, Inhibition of cholesterol absorption in rats by plant sterols. J Lipid Res 29:1573-1582 (1998).
79. Simonsen AC, Bagatolli LA, Duelund L, Garvik O, Ipsen J and Mouritsen OG, Effects of seaweed sterols fucosterol and desmosterol on lipid membranes. Biophys J 96:606a (2009).
80. Dai MC, Chiche HB, Düzgünes N, Ayanoglu E and Djerassi C, Phospholipid studies of marine organisms: 26. Interactions of some marine sterols with 1-stearoyl-2-oleoyl phosphatidylcholine (SOPC) in model membranes. Chem Phys Lipids 59:245-253 (1991).
81. Lampi AM, Dimberg LH and Kamal-Eldin A, A study on the influence of fucosterol on thermal polymerisation of purified high oleic sunflower triacylglycerols. J Sci Food Agric 79:573-579 (1999).
82. Esmon CT, Esmon NL, Saugstad J and Owen WG, Activation of protein C by a complex between thrombin and endothelial cell surface protein in Pathobiology of the Endothelial Cell, ed. by Nossel HL and Vogel HJ. Academic Press, New York, pp. 121-136 (1982).
83. Shimonaka M, Hagiwara H, Kojima S and Inada Y, Successive study on the production of plasminogen activator in cultured endothelial cells by phytosterol. Thromb Res 36:217-222 (1984).